Daniel M. Junius

2012

In 2012, Daniel M. Junius earned a total compensation of $2.4M as President and Chief Executive Officer at ImmunoGen, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$235,200
Option Awards$1,657,800
Salary$480,000
Other$8,832
Total$2,381,832

Junius received $1.7M in option awards, accounting for 70% of the total pay in 2012.

Junius also received $235.2K in non-equity incentive plan, $480K in salary and $8.8K in other compensation.

Rankings

In 2012, Daniel M. Junius' compensation ranked 2,967th out of 11,487 executives tracked by ExecPay. In other words, Junius earned more than 74.2% of executives.

ClassificationRankingPercentile
All
2,967
out of 11,487
74th
Division
Manufacturing
1,040
out of 4,253
76th
Major group
Chemicals And Allied Products
235
out of 1,198
80th
Industry group
Drugs
138
out of 920
85th
Industry
Pharmaceutical Preparations
111
out of 700
84th
Source: SEC filing on September 30, 2014.

Junius' colleagues

We found four more compensation records of executives who worked with Daniel M. Junius at ImmunoGen in 2012.

2012

John Lambert

ImmunoGen

Chief Scientific Officer

2012

Gregory Perry

ImmunoGen

Chief Financial Officer

2012

James O'Leary

ImmunoGen

Chief Medical Officer

2012

Craig Barrows

ImmunoGen

General Counsel

In-depth

You may also like